Eris Lifesciences Limited (NSE:ERIS)

India · Delayed Price · Currency is INR

1,340.90

+4.80 (0.36%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	28.79B	19.91B	16.62B	13.26B	11.93B
Pharmaceuticals Growth	44.59%	19.83%	25.31%	11.20%	12.71%
Total	28.79B	19.91B	16.62B	13.26B	11.93B
Total Growth	44.59%	19.83%	25.31%	11.20%	12.71%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	26.38B	19.45B	16.62B	13.26B	11.93B
India Growth	35.62%	17.03%	25.31%	11.20%	12.71%
outside India	2.42B	465.20M	-	-	-
outside India Growth	419.69%	-	-	-	-
Total	28.79B	19.91B	16.62B	13.26B	11.93B
Total Growth	44.59%	19.83%	25.31%	11.20%	12.71%

Source: S&P Global Market Intelligence.